UiPath CEO sells 45,000 shares at $16.2264 under 10b5-1 plan
UiPath (PATH) CEO and Chairman Daniel Dines reported an insider sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UiPath (PATH) CEO and Chairman Daniel Dines reported an insider sale. On 11/03/2025, he sold 45,000 shares of Class A common stock at an average price of $16.2264, executed under a qualified Rule 10b5-1 trading plan. The reported trade price range was $16.0500 to $16.4200.
Following this transaction, Dines beneficially owned 29,378,585 shares, held directly. He is listed as Director, Officer, and 10% Owner. The filing notes full trade details are available upon request to the company or Commission staff.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 45,000 | $16.2264 | $730K |
Footnotes (2)
- F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- F2. The range of prices for the transactions reported was from $16.0500 to $16.4200. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UiPath (PATH) disclose in this Form 4?
What is Daniel Dines' ownership in PATH after the sale?
Was the PATH insider sale under a prearranged plan?
What roles does the reporting person hold at UiPath (PATH)?
AI-generated analysis. How Rhea-AI works. Not financial advice.